Does C-2 kinin exist? [4]

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 4, 2005, Pages 876-

  Kaplan, Allen P ^a   Ghebrehiwet, Berhane ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; KININ;

AMINO ACID SEQUENCE; BLOOD VESSEL PERMEABILITY; CELL SWELLING; DNA CLEAVAGE; HUMAN; LETTER; MEDICAL LITERATURE; NONHUMAN; PRIORITY JOURNAL;

EID: 16244362328     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.12.1132     Document Type: Letter

References (10)

1. T. Bowen, M. Cicardi, H. Farkas, K. Bork, W. Kreuz, and L. Zingale Canadian 2003 International Consensus Algorithm for the diagnosis, therapy, and management of hereditary angioedema J Allergy Clin Immunol 114 2004 629 637
2. A. Agostoni, E. Aygoren-Pursun, K.E. Binkley, A. Blanch, K. Bork, and L. Bouillet Hereditary and acquired angioedema: problems and progress: proceedings of the third C-1 esterase inhibitor deficiency workshop and beyond J Allergy Clin Immunol 114 suppl 2004 S51 S131
3. T. Fields, B. Ghebrehiwet, and A.P. Kaplan Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C-2 and in support of "spontaneous" formation of bradykinin J Allergy Clin Immunol 72 1983 54 60
4. V.H. Donaldson, F.S. Rosen, and D.H. Bing Roll of the second component of complement (C-2) and plasmin in kinin-release in hereditary angioneurotic edema (H.A.N.E.) plasma Trans Assoc Am Physicians 90 1977 74 83
5. V.H. Donaldson Mechanisms of activation of C-1 esterase in hereditary angioneurotic edema plasma in-vitro: the role of Hageman factor, a clot-promoting agent J Exp Med 127 1968 411 429
6. C.J. Strang, S. Cholin, J. Spragg, A.E. Davis III, C.E. Schneeberger, and V.H. Donaldson Angioedema induced by a peptide derived from complement component C-2 J Exp Med 168 1998 1685 1698
7. L.R. Shoemaker, S.J. Schurman, V.H. Donaldson, and A.H. Davis III Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities Clin Exp Immunol 95 1994 22 28
8. J. Nussberger, M. Cugno, M. Cicardi, and A. Agostoni Local bradykinin generation in hereditary angioedema J Allergy Clin Immunol 104 1999 1321 1322
9. R. Zahedi, J.J. Bissler, A.E. Davis III, C. Andreadis, and J.J. Wisnieski Unique C-1 inhibitor dysfunction in a kindred without angioedema, II: identification of a Ala Val substitution and functional analysis of the recombinant mutant protein J Clin Invest 95 1995 1299 1305
10. E.D. Han, R.C. MacFarlane, A.N. Mulligan, J. Scafidi, and A.E. Davis III Increased vascular permeability in C-1 inhibitor deficiency mice mediated by the bradykinin type 2 receptor J Clin Invest 109 2002 1057 1063